Guard Therapeutics International AB AI Stock Analysis
Guard Therapeutics International AB (5LH0) AI Stock Analysis
Guard Therapeutics International AB
(Frankfurt:5LH0)
No summary available
Guard Therapeutics International AB (5LH0) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 3.84M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- -57.48
- Revenue Growth
- ―
- EPS Growth
- 80.07%
- Country
- Germany
- Employees
- 12
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Guard Therapeutics International AB Business Overview & Revenue Model
Company Description
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard...
Guard Therapeutics International AB Peers Comparison
Overall Rating
SE:ELIC45Neutral
SE:SPAGO42Neutral
SE:MODTX39Underperform
SE:ONCOZ39Underperform
SE:ACE38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | SEK 164.51M | -6.88 | -56.09% | ― | ― | 14.10% | |
| 42Neutral | SEK 35.13M | -1.05 | -87.37% | ― | -97.52% | 31.31% | |
| 39Underperform | SEK 25.61M | -0.83 | -177.45% | ― | ― | 0.22% | |
| 39Underperform | SEK 82.80M | -1.28 | -970.69% | ― | 115.26% | -230.43% | |
| 38Underperform | SEK 79.85M | -1.38 | -62.23% | ― | ― | 50.59% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:5LH0 | Guard Therapeutics International AB | 0.07 | 0.04 | 200.00% | |
| SE:ONCOZ | OncoZenge AB | 3.00 | -1.65 | -35.44% | |
| SE:ELIC | Elicera Therapeutics AB | 2.44 | -2.63 | -51.84% | |
| SE:ACE | Ascelia Pharma AB | 0.59 | -2.21 | -78.93% | |
| SE:MODTX | Modus Therapeutics Holding AB | 0.14 | -0.23 | -62.43% | |
| SE:SPAGO | Spago Nanomedical AB | 0.04 | -0.05 | -54.44% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
